Winton Group’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-11,389
| Closed | -$359K | – | 604 |
|
|
2023
Q4 | $359K | Sell |
11,389
-3,282
| -22% | -$103K | 0.03% | 477 |
|
|
2023
Q3 | $375K | Buy |
14,671
+5,164
| +54% | +$132K | 0.03% | 443 |
|
|
2023
Q2 | $273K | Buy |
+9,507
| New | +$273K | 0.02% | 559 |
|
|
2021
Q4 | – | Sell |
-4,663
| Closed | -$223K | – | 1019 |
|
|
2021
Q3 | $223K | Sell |
4,663
-6,501
| -58% | -$311K | 0.01% | 1202 |
|
|
2021
Q2 | $378K | Buy |
11,164
+500
| +5% | +$16.9K | 0.02% | 1065 |
|
|
2021
Q1 | $440K | Buy |
+10,664
| New | +$440K | 0.03% | 955 |
|